Introduction
Carcinoma of the uterine cervix (CaCx) is the second most common cancer in women worldwide. Infection with HR (high-risk) HPV types is widely acknowledged as the initiating event (IARC, 1995) ; 99.7% of CaCx have been shown positive for one or more of the HR HPV types (Walboomers et al., 1999) . However, there is a large discrepancy between the number of women infected with HPV and those who contract CaCx. This, combined with the long period of latency between manifestation of LSIL (low-grade squamous intraepithelial lesions) and progression to invasive CaCx, suggests that although necessary, infection with HR HPV types alone is not sufficient for progression to CaCx (Zur Hausen, 1991; Zur Hausen and Rosl, 1994) . Obligatory secondary 'hits' are required in the form of cellular genetic changes affecting cellular oncogenes and tumour suppressor genes (Schiffman and Brinton, 1995) . The evidence that high-grade squamous intraepithelial lesions (HSILs) and CaCx are characterized by chromosomal aneuploidy and specific karyotypic abnormalities further supports this theory (Stanley and Sarkar, 1994) .
Histomorphologically defined steps of cellular dysplasia and development of invasive carcinoma can be correlated with recurring chromosomal aberrations. These cytogenetic events are tumour specific and tumour-stage specific, indicating that such aberrations are mandatory events in the progression to invasive carcinoma . The earliest cytogenetic studies of CaCx observed small metacentric marker chromosomes, thought to originate from chromosome 4 or 5 material Baker, 1982, 1984; Herz et al., 1977) . More recent CGH studies have revealed a high level copy increase of 5p to be a recurrent event during progression of advanced stage CaCx (Heselmeyer et al., 1997; Kirchhoff et al., 1999; Ried et al., 1999; Matthews et al., 2000) . Similar markers have been observed in HPV-transformed cell lines (Miller et al., 1971; Durst et al., 1987; Popescu et al., 1987; James et al., 1989; Smith et al., 1989; Macville et al., 1999) . Gain of 5p, however, is not observed in low-grade lesions or HR HPV containing keratinocyte cell lines at early passage in vitro (Cottage et al., 2001) . Amplification of the entire short arm of chromosome 5 suggests the presence of gene(s) whose gain of function seems to be highly advantageous in the progression towards advanced stage CaCx and in CaCx cell lines.
Several candidate genes are situated on this chromosome arm but perhaps the most striking is S-phase kinase-associated protein 2 (SKP2), present at 5p13 (Demetrick et al., 1996) . SKP2 is an F-box protein and part of the SCF complex that acts as an E3 ubiquitin ligase targeting cell-cycle regulators such as p21, p27 and cyclin D1 (Yu et al., 1998; Carrano et al., 1999; Sutterluty et al., 1999; Kudo et al., 2001 ). SKP2 expression is increased in many cancers including lymphomas (Latres et al., 2001) , oral SCC (OSCC) (Gstaiger et al., 2001) , colorectal carcinomas (Hershko et al., 2001 ) and prostate cancer . Increased expression of SKP2 in OSCC has been correlated with poor prognosis and severity of lesion, carcinomas showing greater expression levels than epithelial dysplasias (Gstaiger et al., 2001; Kudo et al., 2001) . In human lymphomas, SKP2 expression correlates directly with the grade of malignancy and inversely with p27 levels (Latres et al., 2001) . Induction of Skp2 mRNA is exclusively dependant upon cell adhesion to the extracellular matrix ). This together with the high Skp2 levels observed in human cancers suggests a role for Skp2 in adhesionindependent tumour growth.
Although data from in vitro models should be treated with caution when extrapolating to the in vivo setting, the available evidence suggests that the molecular genetic abnormalities seen in HPV immortalized and CaCx cell lines resemble those in the SIL/carcinoma spectrum (Stanley and Sarkar, 1994) . In the present study, we report recurrent cytogenetic aberrations observed by M-FISH in 12 HR HPV containing CaCx-derived cell lines and 1 HPV negative SCC of the cervix. The status of chromosome 5 in each line and HeLa has been confirmed by human band-specific painting. The HPV16-harbouring cell line W12 shows progressive morphological abnormality with in vitro passage culminating in an invasive phenotype (Pett, PhD Thesis, University of Cambridge, 2002) and gain of 5p is observed at passage 24. W12 has been utilized in the present study as a model for the progression of LSIL to invasive CaCx. Quantitative real-time PCR has been used to investigate levels of Skp2 transcript in serial passes of W12, while immunoblot has been utilized to detect levels of Skp2 protein and its target p27. The following report provides preliminary evidence for the involvement of SKP2 in cancer progression of the cervix.
Results

M-FISH analysis detects structural aberrations and ploidy changes in CaCx-derived cell lines
M-FISH analysis of eight new cell lines derived from CaCx biopsies and five established CaCx lines (see Table 1 Composite karyotypes for CaSki, SiHa and C33a determined by M-FISH analysis were reported previously by us (Cottage et al., 2001) .
Cell lines 778, 808, 866, 877, 878, 879 and 915 were all derived from CaCx biopsies taken prior to treatment. These cell lines revealed highly rearranged karyotypes and varied in ploidy from pseudodiploid to pentaploid. Composite karyotypes for each of these lines are not presented here but a summary of the aberrations observed for each chromosome is shown in Table 2 .
Chromosome 5 painting shows this chromosome to be frequently over-represented in HPV-containing CaCx-derived lines Metaphase spreads painted with digoxigenin-labelled probe for chromosome 5 and Spectrum Orange-labelled centromeric probe, 5 pcen, supported M-FISH data and showed a gain of chromosome 5 material in 11 of 13 HPV-containing lines. In cell lines 778, 808, 873, 878, 915, C4-1, HeLa and SiHa this gain was represented by one or more small metacentric chromosome 5s. Gain of whole chromosome 5 was observed in cell line 879.
Band-specific painting confirms 5p amplification
Band-specific painting was used to further examine the region of chromosome 5 being amplified in CaCx lines. Metaphases were painted with band-specific paints Whole chromosomal losses are depicted in blue, whole chromosomal gains in red and structural rearrangements in green. Structural rearrangement with chromosomal loss or gain is shown in yellow. The number of metaphases in which a particular abnormality is seen is shown in square brackets [ ]. The total number of metaphases captured for a particular cell line is shown in square brackets under the name of the respective cell line (+, whole chromosomal gain; À, whole chromosomal loss; t, translocation; del, deletion of chromosomal fragment; I, isochromosome; hsr, homologously staining region) 5p and Skp2 in HPV-immortalised keratinocytes SE Dowen et al pertaining to regions 5p13, 5p11-12, 5pcen, 5q11, 5q12 ( Figure 1 ). Isochromosome 5p (i(5p)) was seen in cell lines 778 (2-4copies), 808 (two copies), 873(one copy), 878 (one copy), 915 (three copies), C4-1 (one copy), HeLa (four copies) and SiHa (two copies). Alongside isochromosome formation, translocation of the p arm of chromosome 5 was seen in cell lines 873 der(5;15) (p10;q10?) and 878 der(5;16) (p10;?). Translocation of 5p resulting in net gain of this chromosome arm (without the presence of i(5p)) was observed in two cell lines: CaSki der(5;?) (p10;?) x3, ins(3;5) (p?::p10-p13::p?::p10-p13::p?::p10-p13::p?-pter) and MS751 (Table 1 ) was hybridized to whole chromosome 5 probe (green) and the centromeric probe 5pcen (red); bands A: 5p13 (magenta) and 5q12 (yellow); bands B: 5p11-12 (green) and 5q11 (blue). The figure shows all the aberrations of chromosome 5 observed in each CaCx-derived cell line 5p and Skp2 in HPV-immortalised keratinocytes SE Dowen et al
Gain of chromosome 5p correlates with increased Skp2 transcription in W12
Metaphases from the cell line W12 at passes 11, 17, 20, 24, 33 and 48 were hybridized to chromosome 5 bandspecific paints pertaining to regions 5p13, 5p11-12, 5pcen, 5q11 and 5q12. Gain of 5p in the form of an isochromosome was observed at passage 24 (Figure 2) .
The effect of i(5p) gain on Skp2 transcription in W12 was measured by real-time PCR. Total RNA from cells at passes 11 and 20 (prior to gain of i(5p)) and passes 24, 43 and 60 (post i(5p) gain) were assayed for the expression of Skp2 mRNA. The results show a significant fourfold increase in Skp2 expression at passage 24 (P ¼ 0.03) compared to the level of Skp2 transcription at passage 20 prior to gain of 5p (Figure 3 ). This increase in Skp2 expression is maintained at later passes 43 and 60.
Expression of Skp2 increases and correlates with reduced p27 expression in W12 at serial passage Expression of Skp2 and p27 was investigated by immunoblot using protein extracts from W12 at passes 14, 24, 35 and 56. 15 mg of total protein was loaded for each sample. Immunoblotting results for Skp2 and p27 can be seen in Figure 4a . Total protein extracts from normal cervical epithelia and from the established cell lines HeLa and SiHa were also used. It is apparent from Figure 4a and b that Skp2 is absent in normal cervical keratinocytes while in W12 its expression increases with passage, correlating with the acquisition of i(5p). Skp2 was present at a high level in protein extracts from both HeLa and SiHa CaCx cell lines. Figure 4 reveals p27 expression to correlate inversely with cell passage and expression levels of Skp2 in W12. p27 was found to be expressed in normal cervical epithelia, correlating with an absence of Skp2. p27 was expressed in W12 p14 at a higher level than normal keratinocytes. This may be explained by the presence of HPV oncoproteins E6/7, which interfere with the phosphorylation of p27 and therefore its degradation. This effect may be overcome at later passage by the increased level of Skp2.
Discussion
M-FISH was used to determine the presence of specific chromosomal abnormalities in HR HPV-containing CaCx-derived cell lines. Aberrations of each chromosome were observed; however, the most striking were structural rearrangements and gain of chromosomes 5 a b c (Cuthill et al., 1999; Reznikoff et al., 1994; Savelieva et al., 1997) and trisomy of chromosome 20 is observed in human prostate epithelial cells immortalized with HPV16 E6 and E7. M-FISH data revealed amplification of chromosome 5 material to be a consistent event, as a result of small metacentric chromosome formation or translocation. Gain of 5p is a late event, observed in established cell lines but is not in HPV immortalized lines at early passage (Cottage et al., 2001) . Single chromosome 5 painting confirmed these findings. Band-specific painting identified the region of amplification on chromosome 5, in the present study, to include at least 5pcen to 5p13. In 8 out of 11 cases amplification of chromosome 5 material was seen in the form of small metacentric chromosomes. Small metacentric chromosomes have been observed in metaphase preparations from CaCx samples for many years Baker, 1982, 1984; Herz et al., 1977) ; these were often suspected to be i(4p) or i(5p). In the case of this study, band-specific painting allowed unequivocal identification of the metacentric chromosomes as i(5p).
Gain of 5p is a common event in vivo and CGH studies of CaCx have observed gain of 5p to correlate with the presence of advanced stage disease (Heselmeyer et al., 1997; Kirchhoff et al., 1999) . Most CGH studies agree that gain of 5p is only observed in advanced stage disease. However, gain of 5p was observed by Aubele et al. (1998) in dysplastic cells and considered to be a marker of progressive disease.
The observations described in the present study suggest that gain of 5p correlates with disease progression and indicates the presence of a gene(s) on chromosome arm 5p whose gain of function is advantageous to tumorigenesis and progression towards invasive CaCx. Several candidate genes are situated on this chromosome arm including Skp2 and hTERT, the catalytic subunit of telomerase. Telomerase activity has previously been studied in the cell line W12 (Pett, PhD Thesis, University of Cambridge, 2002) where it was found to be present and maintained at a constant level from an early passage. Therefore, we considered gain of hTERT activity to be unrelated to the amplification of 5p. The F-box protein Skp2, present at 5p13 (Demetrick et al., 1996) , was regarded as the most likely candidate to be involved in CaCx progression as a result of 5p gain.
Skp2 and one of its targets, p27, have been implicated in the development of metastases. In colorectal tumours, reduced p27 expression has been observed in metastases compared with the corresponding primary tumour (Loda et al., 1997; Ciaparrone et al., 1998) . Low or absent p27 expression has been correlated with more advanced tumour stage, invasive phenotypes and poor patient prognosis. Low levels of p27 observed in many cancers have been correlated with an increased presence of Skp2, for example in human lymphomas (Latres et al., 2001) , OSCC (Kudo et al., 2001) , colorectal cancer (Hershko et al., 2001 ) and prostate cancer .
The cell line W12 was derived from LSIL and contains HPV16 in its episomal form at early passage. In the present study, W12 has been used as a model system to analyse Skp2 expression. W12 shows progressive morphological change with serial passage in organotypic culture; the episomal form is lost, viral genomes integrate (Jeon et al., 1995) and at late passage cells exhibit an invasive phenotype (Pett, PhD Thesis, University of Cambridge, 2002). Band-specific painting revealed W12 to exhibit gain of 5p in the form of an isochromosome at passage 24. Real-time PCR found this to correlate with a fourfold increase in Skp2 transcription and immunoblotting revealed protein expression of Skp2 to increase with passage of W12. Levels of Skp2 expression, similar to those of the established CaCx lines SiHa and HeLa, were achieved after passage 24, postgain of 5p, while normal cervical keratinocytes were found to be Skp2-negative. p27 expression correlated inversely with Skp2 expression and W12 passage. p27 was found to be present in normal cervical keratinocytes; however, it was expressed at a higher level in W12 p14. This may be explained in part by the presence of HPV E7. The HPV oncoprotein E7 is known to interact physically with p27 preventing its association with and inhibition of Cyclin A/E-Cdk2 complexes (Zur Hausen, 2000) . However, obstruction of the p27-Cdk2 interaction, by E7, also prevents the . The identity of the band containing Skp2 was determined by immunoprecipitation using protein G-coated sephrose. HeLa (1) and normal keratinocyte (2) extracts were used. This method revealed the Skp2-containing band to be the lower of the two o48 kDa. This band was absent in normal cervical keratinocytes.
In both extracts a band consisting of IgG heavy chains can be seen.
(b) Western blot analysis of Skp2 and p27 expression patterns in W12 at serial passage. Total cellular protein extracts from W12 cells at passages 14 (1), 24 (2), 35(3), 56(4), normal cervical keratinocytes (5) and CaCx lines HeLa (6) and SiHa (7) were analysed. A measure of 15 mg of total protein for each sample was loaded on 8 and 12.5% SDS-PAGE gels for fractionation of Skp2 and p27, respectively 5p and Skp2 in HPV-immortalised keratinocytes SE Dowen et al phosphorylation of p27, which marks it for degradation, this may be overcome at later passes by an increased level of Skp2. The observations of the current study agree with the results of other cancer studies, which have demonstrated increased Skp2 levels in their more severe forms (Hershko et al., 2001; Kudo et al., 2001; Latres et al., 2001) . Our findings suggest that high expression of Skp2 may be associated with both gain of 5p and progression towards a more invasive phenotype. Carrano and Pagano (2001) revealed transcription of Skp2 to be dependent upon ECM-cell adhesion signalling. ECM-cell adhesion signalling is a requirement for progression through G 1 and ectopic Skp2 expression results in S phase entry. If control of Skp2 expression is abrogated and high levels are achieved, as has been observed in many cancers, the requirement of cell adhesion for progression into S phase may be removed. This hypothesis is supported by the findings that enforced expression of Skp2 in adhesion-dependent fibroblasts results in the acquisition of adhesionindependent growth . Mitogens increase Skp2 levels as a result of stabilizing Skp2 protein, whereas ECM signalling increases SKP2 transcription ). Upregulation of SKP2 gene transcription may be achieved in CaCx by the gain of extra copies of SKP2, a result of 5p amplification. This was the observed in W12. Potentially, the gain of SKP2 copy number, because of amplification of 5p, could overcome cell adhesiondependent growth in cervical tumour cells, resulting in an invasive phenotype.
Materials and methods
Cell lines, culture conditions and metaphase preparation
The cell lines analysed are shown in Table 1 . The cell lines CaSki, SiHa, C4-1, MS751, HeLa and C33a were grown in Dulbecco's modified Eagle's medium supplemented with 10% foetal bovine serum. Cell lines 778-915 (Brady et al., 2000) were cultured according to conditions previously outlined for keratinocyte culture by Stanley and Greenfield (1991) .
Metaphase chromosomes for M-FISH, single chromosome and band-specific painting were prepared as follows: cells were incubated in medium containing 0.1 mg/ml Colcemid (Invitrogen) for 40 min, they were then lysed at 371C for 15 min in 75 mm KCl and fixed in methanol : acetic acid (3 : 1). Metaphase preparations were then stored at À201C until required.
M-FISH analysis
M-FISH hybridization was conducted using the protocol of Roberts et al. (1999) . Four standard paint sets, each of which hybridized to six chromosomes, were used (Set A: Chr. 1, 2, 3, 4, 5 and 6; Set B: Chr. 7, 8, 9, 10, 11 and 12; Set C: Chr. 13, 14, 15, 16, 17 and 18; Set D: Chr. 19, 20, 21, 22, X and Y) . Translocation partners were then confirmed with tailored paint sets. An Axioplan II fluorescence microscope (Zeiss) equipped with filter sets for DAPI, FITC, Cy3 and Cy5 (Chroma Technology Ltd) was used for visualizing the M-FISH slides. A Sensys CCD camera (Photometrics) was used in conjunction with SmartCapture VP software (Digital Scientific) for the M-FISH analysis. Ten metaphases were analysed for each paint set; at least 40 metaphases were analysed for each cell line.
Chromosome 5 painting
Metaphase spreads derived from all cell lines (see Table 1 ) were hybridized with a labelled chromosome 5 probe. Flow-sorted chromosome 5 DNA was amplified by DOP PCR (Telenius et al., 1992a, b) and labelled with digoxigenin-11-dUTP (Roche). Digoxigenin-labelled chromosome 5 products were detected using antidigoxigenin FITC-conjugated FAB fragments (Roche). Imaging and analysis of chromosome 5 was conducted as described previously for M-FISH. For each cell line at least 20 metaphases were analysed.
Chromosome 5 band-specific painting All cell lines (see Table 1 ) were analysed with band-specific probes for chromosome 5; 5p13, 5p11-12, 5pcen, 5q11 and 5q12 using the protocol provided by the manufacturer (Research Genetics). Probes were made containing the indirect substituted nucleotides biotin 16-dUTP and dioxigenenin 11-dUTP (Roche), and the direct fluorescent label Spectrum Orange (Vysis). Immunofluorescent detection of the indirect labelling components was undertaken using antidigoxigenin FITC-conjugated FAB fragments (Roche) and Streptavidin Cy5 (Amersham). Imaging and analysis was performed as for M-FISH. For each cell line 20 metaphases were analysed.
Total RNA extraction and reverse transcription
Total RNA was extracted from cells at 80% confluence using RNA-Xcell reagent (Biogene) according to the manufacturer's instructions. RNA was DNase I treated using Message Clean kit (Genhunter) as described by the manufacturer. cDNA was synthesized from 2 mg of total RNA in a 20 ml reaction with Superscript II (Invitrogen).
TaqMan real-time PCR
Real-time PCR was performed using the ABI Prism 7700 Sequence Detection System and TaqMan Universal PCR Master mix (PE Applied Biosystems). TaqMan PCR primers, 5 0 -TCGGTTGCTGTCTCAAGGG-3 0 (forward primer), 5 0 -CAGCCAATGGTTGGTCCATAA-3 0 (reverse primer) and FAM-labelled probe, 5 0 -ATTGCCTTCCGCTGCCCACGA-3 0 , for Skp2 were designed using Primer Express software (PE Applied Biosystems). GAPDH was used as an endogenous control and was amplified using GAPDH control reagents (PE Applied Biosystems). All primers and probes were used at final concentrations of 40 and 10 nm, respectively. A total of 2 ml cDNA were added per reaction. Amplification conditions were: 2 min at 501C; 10 min at 951C, followed by a two-step cycle at 951C for 15 s and 601C for 60 s for a total of 40 cycles. Reactions were conducted in triplicate. Standard curves were obtained by amplification of a dilution series of cDNA from W12 at passage 11. Results for Skp2 were normalized to GAPDH and calibrated using values for W12 at passage 11 to obtain fold change values for Skp2 mRNA levels. A Student's t-test was used to determine the significance of any difference in Skp2 expression before and after gain of 5p. A P value of less than 0.05 was considered significant.
Western blotting
Protein extracts from serial passages of W12 were prepared by washing the cells from a 10 cm dish three times in ice-cold 5p and Skp2 in HPV-immortalised keratinocytes SE Dowen et al phosphate-buffered saline (PBS), followed by lysis in 300 ml of NP-40 lysis buffer (250 mm sodium chloride, 0.1% Nonidet P-40, 50 mm HEPES pH 7.4) containing protease inhibitors (one complete mini-protease inhibitor cocktail tablet (Roche) in 25 ml). The protein concentrations of the lysates were determined at a wavelength of 595 nm using Bio-Rad protein assay. Protein lysates were diluted in SDS-PAGE sample buffer and the proteins denatured at 951C for 10 min. A total of 15 mg of total protein for each sample were fractionated on an 8% polyacrylamide gel for the detection of Skp2 and a 12.5% polyacrylamide gel for the detection of p27. Proteins were transferred onto nitrocellulose membranes and subjected to standard Western blotting analysis. For the detection of Skp2, a mouse monoclonal antibody (Zymed) was diluted 1 : 200 and for the detection of p27, a rabbit polyclonal antibody (Abcam) was also diluted 1 : 200. Primary antibodies were detected using the anti-mouse or anti-rabbit HRP-conjugated secondary antibodies (1 : 1000) (DAKO) and visualized using chemiluminescence (ECL kit, Amersham).
The anti-Skp2 monoclonal detected two bands of similar size. The identity of Skp2 was determined using Protein G-coated sephrose beads (Pharmacia) (data not shown). A total of 65 mg of total protein was incubated overnight at 41C with 2 mg of anti-Skp2 mouse monoclonal antibody (Zymed). Protein G-coated sephrose beads were added and incubated with the protein extract for 1 h at 41C. Beads were pelleted and the supernatant removed. Proteins were removed from the beads in SDS-PAGE sample buffer, beads pelleted and the supernatant separated as for Western blotting.
